Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Activation of post-synaptic serotonin 1A (5-HT1A) receptors is a potential therapeutic strategy for depression.
• Understanding the signal transduction pathways of novel 5-HT1A receptor agonists is crucial for drug development.

Purpose of the Study:

• To characterize the signal transduction profile of F15599, a novel 5-HT1A receptor agonist.
• To compare F15599's signaling profile with existing agonists like F13714 and (+)8-OH-DPAT.

Main Methods:

• In vitro and ex vivo assays were used to assess F15599's binding affinity and signaling activities.
• Experiments included [(35)S]-GTPgammaS binding, extracellular signal-regulated kinase (ERK1/2) phosphorylation, G-protein activation, and c-fos mRNA expression.
• Studies were conducted in cell lines expressing human 5-HT1A receptors and in rat brain regions.

Main Results:

• F15599 exhibited high selectivity for 5-HT1A receptors.
• F15599 preferentially stimulated ERK1/2 phosphorylation and G(alphai) activation over other pathways.
• In rat prefrontal cortex, F15599 potently activated ERK1/2 phosphorylation and induced c-fos mRNA expression, consistent with post-synaptic 5-HT1A receptor activity.

Conclusions:

• F15599 displays a distinct functional selectivity profile at 5-HT1A receptors compared to reference agonists.
• The potent activation of signaling in the prefrontal cortex by F15599 is likely responsible for its beneficial effects in models of depression and cognition.
• F15599 represents a promising novel agonist for targeting 5-HT1A receptor-mediated pathways.